Results 41 to 50 of about 10,536,235 (262)

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

open access: yesAnnals of the Rheumatic Diseases, 2019
To update the European League Against Rheumatism (EULAR) recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) published in 2011.
V. Furer   +20 more
semanticscholar   +1 more source

2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases

open access: yesAnnals of the Rheumatic Diseases, 2022
Background Remote care and telehealth have the potential to expand healthcare access, and the COVID-19 pandemic has called for alternative solutions to conventional face-to-face follow-up and monitoring.
A. de Thurah   +29 more
semanticscholar   +1 more source

Consensus of Chinese Experts on the Diagnosis and Treatment of Type Ⅰ Interferonopathy

open access: yes罕见病研究
Type Ⅰ interferonopathy is an autoinflammatory disease that affects multiple systems, with a high disability and mortality rate. It profoundly impacts the quality of life of patients and poses a considerable burden on their families and society.
Chinese Alliance of Pediatric Rheumatic & Immunologic Diseases   +1 more
doaj   +1 more source

Sustained Drug Free Remission of Lupus Panniculitis with Methotrexate: A Report From Nepal

open access: yesJournal of Nepal Medical Association, 2018
Cutaneous manifestations are second most common presenting feature of lupus. Discoid lupus erythematosus is the most common variant amongst all; lupus panniculitis being described in only 2-5% of cases.
Binit Vaidya   +3 more
doaj   +1 more source

2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases

open access: yesArthritis care & research
We provide evidence‐based recommendations regarding the treatment of interstitial lung disease (ILD) in adults with systemic autoimmune rheumatic diseases (SARDs).
S. Johnson   +60 more
semanticscholar   +1 more source

Rituximab used for simultaneous treatment of PR3‐ANCA positive vasculitis associated with rheumatoid arthritis: A case report

open access: yesClinical Case Reports, 2020
We treated PR3‐ANCA positive vasculitis in a patient diagnosed with rheumatoid arthritis using rituximab. Monoclonal antibody therapy can be used to simultaneous treat more than one collagen disease in such patients.
Akihiro Yamada   +2 more
doaj   +1 more source

Increased risk of malignancy in patients with systemic lupus erythematosus: population-based cohort study in Korea

open access: yesArthritis Research & Therapy, 2021
Background This study aimed to evaluate the crude incidence rates and relative risk of malignancy in Korean patients with SLE. Methods We conducted a retrospective nationwide cohort study using databases from the National Health Insurance Service in ...
Jung-Yong Han   +5 more
doaj   +1 more source

Reduced Humoral Response of SARS-CoV-2 Antibodies following Vaccination in Patients with Inflammatory Rheumatic Diseases—An Interim Report from a Danish Prospective Cohort Study

open access: yesVaccines, 2021
Background/Purpose: In light of the current COVID-19 pandemic, whether patients with rheumatic musculoskeletal disease (RMD) treated with conventional (cs) or biologic (b) disease-modifying drugs (DMARDs) exhibit an adequate immune response to the ...
Karen Schreiber   +8 more
doaj   +1 more source

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

open access: yesThe Lancet Rheumatology, 2021
Background Various observations have suggested that the course of COVID-19 might be less favourable in patients with inflammatory rheumatic and musculoskeletal diseases receiving rituximab compared with those not receiving rituximab.
J. Avouac   +464 more
semanticscholar   +1 more source

Effectiveness of bazedoxifene in preventing glucocorticoid-induced bone loss in rheumatoid arthritis patients

open access: yesArthritis Research & Therapy, 2021
Objective To evaluate the effectiveness of bazedoxifene in preventing bone loss in patients with rheumatoid arthritis (RA) receiving low-dose glucocorticoids (GCs).
Soo-Kyung Cho   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy